Therapeutic Potential for B-Cell Modulation in Sjogren's Syndrome

B-cell hyperactivity has been recognized for a long time in Sjogren's syndrome. This B-cell activation is firstly polyclonal but can progress to monoclonal B-cell lymphoproliferation. This article addresses the therapeutic potential of B-cell modulation in Sjogren's syndrome.